Revive Therapeutics

(OTC) RVVTF

Current Price$0.02

Market Cap$9.17M

Since IPO (2015)-96%

5 Year-94%

1 Year+20%

1 Month-26%

Revive Therapeutics Financials at a Glance

Market Cap

$9.17M

Revenue (TTM)

$0.00

Net Income (TTM)

$10.69M

EPS (TTM)

$-0.02

P/E Ratio

-1.20

Dividend

$0.00

Beta (Volatility)

-0.03 (Low)

Dividend

$0.00

Beta (Volatility)

-0.03 (Low)

Price

$0.02

Volume

152,544

Open

$0.02

Price

$0.02

Volume

152,544

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.01 - $0.06

Dividend

$0.00

Beta (Volatility)

-0.03 (Low)

Price

$0.02

Volume

152,544

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.01 - $0.06

RVVTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Revive Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

CEO

Michael Frank

Website

www.revivethera.com

Headquarters

Toronto, ON M5C 1P1, CA

RVVTF Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-897%

Return on Capital

37%

Return on Assets

-41%

Earnings Yield

-83.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.17M

Shares Outstanding

418.56M

Volume

152.54K

Avg. Volume

630.76K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.65M

EBITDA

$11.01M

Operating Cash Flow

$767.66K

Capital Expenditure

$0.00

Free Cash Flow

$767.66K

Cash & ST Invst.

$14.56K

Total Debt

$66.87K

Revive Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$47.96

N/A

Gross Margin

0.00%

N/A

Market Cap

$9.17M

N/A

Market Cap/Employee

$3.06M

N/A

Employees

N/A

Net Income

$238.53K

+34.6%

EBITDA

$280.21K

+23.2%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$46.57K

-184.0%

Accounts Receivable

$39.38K

+5502.0%

Inventory

$0.00

N/A

Long Term Debt

$69.43K

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-40.92%

N/A

Return on Invested Capital

36.60%

N/A

Free Cash Flow

$142.41K

+69.7%

Operating Cash Flow

$142.41K

+69.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CPIVFCaptiva Verde Wellness Corp.

CPIVFCaptiva Verde Wellness Corp.$0.03+4.00%

CNGGFCann Group Limited

CNGGFCann Group Limited$0.01+61.54%

RAFARafarma Pharmaceuticals, Inc.

RAFARafarma Pharmaceuticals, Inc.$0.05-16.53%

TGIFF1933 Industries Inc.

TGIFF1933 Industries Inc.$0.01+8.07%

CANNTrees Corporation

CANNTrees Corporation$0.02-10.61%

SLDXStella Diagnostics Inc.

SLDXStella Diagnostics Inc.$0.01+0.00%

LMLLFPharmadrug Inc.

LMLLFPharmadrug Inc.$0.01-15.80%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.60+0.00%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.41-0.00%

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF$6.87-0.08%

MARAMara Holdings

MARAMara Holdings$13.35+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.90+0.08%

NOKNokia

NOKNokia$13.93+0.09%

NVDANvidia

NVDANvidia$219.12+0.02%

Questions About RVVTF

What is the current price of Revive Therapeutics?

Revive Therapeutics is trading at $0.02 per share.

What is the 52-week range for Revive Therapeutics?

Over the past 52 weeks, Revive Therapeutics has traded between $0.01 and $0.06.

How much debt does Revive Therapeutics have?

As of the most recent reporting period, Revive Therapeutics reported total debt of $50,693.416.

How much cash does Revive Therapeutics have on hand?

Revive Therapeutics reported $16,693.781 in cash and cash equivalents in its most recent financial results.

What is Revive Therapeutics’s dividend yield?

Revive Therapeutics does not currently have a dividend yield.

Revive Therapeutics

Revive Therapeutics Financials at a Glance

RVVTF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Revive Therapeutics

RVVTF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Revive Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RVVTF

What is the current price of Revive Therapeutics?

What is the 52-week range for Revive Therapeutics?

How much debt does Revive Therapeutics have?

How much cash does Revive Therapeutics have on hand?

What is Revive Therapeutics’s dividend yield?

Premium Investing Services